Back to results
US 11,529,406 B2Granted
Clostridium perfringens bacteriophage Clo-PEP-2 and use for inhibiting Clostridium perfringens proliferation of same
AssigneeIntron Biotechnology, Inc.
InventorsSeong Jun Yoon, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Hee Jeong Shin, Sang Hyeon Kang
Life of this patent
Estimating the term…
Abstract
The present invention relates to Siphoviridae bacteriophage Clo-PEP-2 (accession number KCTC 13185BP), separated from nature, which is capable of killing Clostridium perfringens and has a genome expressed by sequence number 1 and a method for preventing or treating diseases, induced by Clostridium perfringens, by means of a composition comprising the Siphoviridae bacteriophage Clo-PEP-2 as an active ingredient.
Claims1
A method of preventing or treating a disease caused by Clostridium perfringens, the method comprising:
- administering to an animal other than a human a composition comprising an effective amount of Siphoviridae bacteriophage Clo-PEP-2 having a genome set forth in SEQ ID NO:
- 1 and deposited under the accession number of KCTC 13185BP, which has an ability to kill Clostridium perfringens.
Dependencies are inferred from the claim text.